Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.01 USD | -0.60% | +0.72% | -2.71% |
11:49am | Pfizer announces 500 million euros investment in France | RE |
09/05 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
Sales 2024 * | 60.41B 5,043B | Sales 2025 * | 62.71B 5,235B | Capitalization | 159B 13,252B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B 649B | Net income 2025 * | 11.29B 942B | EV / Sales 2024 * | 3.59 x |
Net Debt 2024 * | 58.11B 4,852B | Net Debt 2025 * | 49.97B 4,172B | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
19.5
x | P/E ratio 2025 * |
13.7
x | Employees | 88,000 |
Yield 2024 * |
5.96% | Yield 2025 * |
6.07% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | -0.60% | ||
1 week | +0.72% | ||
Current month | +9.33% | ||
1 month | +6.34% | ||
3 months | +1.63% | ||
6 months | -4.99% | ||
Current year | -2.71% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/93/01 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/22/02 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/20/01 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/17/23 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/13/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 0 M€ | +12.39% | - | |
9.37% | 0 M€ | +7.69% | - |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 28.01 | -0.60% | 25,849,775 |
09/24/09 | 28.18 | -0.32% | 47,831,087 |
08/24/08 | 28.27 | +1.80% | 39,087,790 |
07/24/07 | 27.77 | -1.38% | 65,606,379 |
06/24/06 | 28.16 | +1.26% | 59,899,707 |
Delayed Quote Nyse, May 11, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.71% | 159B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PFE Stock